All In Biotech

NDA 020516 · Kenvue Brands

Children'S Motrin

Ibuprofen · Oral · Nonsteroidal Anti-inflammatory Drug

Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1995

Jun 16, 1995

Approved uses

1

Original approval plus efficacy supplements

Registered trials

910

162 Phase 3, 61 recruiting

FAERS reports

207,153

149,068 serious, 16,562 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 8, 2024.

Uses temporarily: relieves minor aches and pains due to the common cold, flu, sore throat, headache and toothache reduces fever

Therapeutic areas: Pain and anesthesia

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jun 16, 1995 Original approval · Type 8 - Partial Rx to OTC Switch
2 products under this application
  • CHILDREN'S MOTRIN · IBUPROFEN 100MG/5ML · SUSPENSION, ORAL · Over-the-counter
  • MOTRIN IB · IBUPROFEN 200MG/10ML · SUSPENSION, ORAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Ibuprofen" as an intervention, any sponsor and status, largest first.

All 910 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective16,396
  • pain15,353
  • fatigue14,866
  • nausea13,934
  • headache12,388
  • arthralgia11,148
  • dyspnoea10,814
  • vomiting10,424
  • diarrhoea10,065
  • rash9,328
  • off label use9,255
  • dizziness8,413

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20041,642
20052,167
20062,083
20072,158
20081,815
20092,829
20104,550
20115,826
20127,159
20136,948
20146,643
20159,629
201613,005
201711,791
201816,008
201917,043
202015,766
202115,499
202214,954
202314,097
202413,055
202513,230
20269,247

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 2,679 on PubMed

Sponsor: Kenvue Brands · Also marketed as Motrin Ib

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.